p53 amyloid aggregation in cancer: function, mechanism, and therapy

J Li, M Guo, L Chen, Z Chen, Y Fu, Y Chen - Experimental Hematology & …, 2022 - Springer
Similar to neurodegenerative diseases, the concept that tumors are prion like diseases has
been proposed in recent years. p53, the most well-known tumor suppressor, has been …

Inhibition of p53 protein aggregation as a cancer treatment strategy

K Kwan, O Castro-Sandoval, C Gaiddon… - Current Opinion in …, 2023 - Elsevier
The p53 protein plays a critical role in the prevention of genome mutations in the body,
however, this protein is frequently mutated in cancer and almost all cancers exhibit …

Discovery of nanomolar-affinity pharmacological chaperones stabilizing the oncogenic p53 mutant Y220C

JR Stephenson Clarke, LR Douglas… - ACS pharmacology & …, 2022 - ACS Publications
The tumor suppressor protein p53 is inactivated in the majority of human cancers and
remains a prime target for developing new drugs to reactivate its tumor suppressing activity …

Transcript errors generate amyloid-like proteins in huwman cells

CS Chung, Y Kou, SJ Shemtov, BM Verheijen… - Nature …, 2024 - nature.com
Aging is characterized by the accumulation of proteins that display amyloid-like behavior.
However, the molecular mechanisms by which these proteins arise remain unclear. Here …

Mutant p53 as a regulator and target of autophagy

Y Shi, E Norberg, H Vakifahmetoglu-Norberg - Frontiers in oncology, 2021 - frontiersin.org
One of the most notoriously altered genes in human cancer is the tumor-suppressor TP53,
which is mutated with high frequency in more cancers than any other tumor suppressor …

Mutant p53 in cell-cell interactions

S Pilley, TA Rodriguez, KH Vousden - Genes & development, 2021 - genesdev.cshlp.org
Abstract p53 is an important tumor suppressor, and the complexities of p53 function in
regulating cancer cell behaviour are well established. Many cancers lose or express mutant …

Hyperosmotic phase separation: Condensates beyond inclusions, granules and organelles

AP Jalihal, A Schmidt, G Gao, SR Little… - Journal of Biological …, 2021 - ASBMB
Biological liquid–liquid phase separation has gained considerable attention in recent years
as a driving force for the assembly of subcellular compartments termed membraneless …

From cultivation to cancer: formation of N-nitrosamines and other carcinogens in smokeless tobacco and their mutagenic implications

SB Stanfill, SS Hecht, AC Joerger… - Critical Reviews in …, 2023 - Taylor & Francis
Tobacco use is a major cause of preventable morbidity and mortality globally. Tobacco
products, including smokeless tobacco (ST), generally contain tobacco-specific N …

GAS5‑mediated regulation of cell signaling

Y Zhou, B Chen - Molecular medicine reports, 2020 - spandidos-publications.com
In recent years, an increasing number of long non‑coding RNAs (lncRNAs) have been
discovered using microarrays and nucleic acid sequencing technology. LncRNAs exert …

Protein of a thousand faces: The tumor-suppressive and oncogenic responses of p53

MA Marques, GC Andrade, JL Silva… - Frontiers in molecular …, 2022 - frontiersin.org
The p53 protein is a pleiotropic regulator working as a tumor suppressor and as an
oncogene. Depending on the cellular insult and the mutational status, p53 may trigger …